Torchilin V - Search Results

1

Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance.

Zamboni WC, Torchilin V, Patri AK, Hrkach J, Stern S, Lee R, Nel A, Panaro NJ, Grodzinski P. Zamboni WC, et al. Among authors: torchilin v. Clin Cancer Res. 2012 Jun 15;18(12):3229-41. doi: 10.1158/1078-0432.CCR-11-2938. Epub 2012 Jun 5. Clin Cancer Res. 2012. PMID: 22669131 Free PMC article. Review.

2

Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.

ElBayoumi TA, Torchilin VP. ElBayoumi TA, et al. Clin Cancer Res. 2009 Mar 15;15(6):1973-80. doi: 10.1158/1078-0432.CCR-08-2392. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276264 Free PMC article.

3

Nanopreparations for organelle-specific delivery in cancer.

Biswas S, Torchilin VP. Biswas S, et al. Adv Drug Deliv Rev. 2014 Feb;66:26-41. doi: 10.1016/j.addr.2013.11.004. Epub 2013 Nov 21. Adv Drug Deliv Rev. 2014. PMID: 24270008 Free PMC article. Review.

4

Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs' Dosage Ratio Effect.

Pan J, Rostamizadeh K, Filipczak N, Torchilin VP. Pan J, et al. Molecules. 2019 Mar 15;24(6):1035. doi: 10.3390/molecules24061035. Molecules. 2019. PMID: 30875934 Free PMC article. Review.

5

Targeted pharmaceutical nanocarriers for cancer therapy and imaging.

Torchilin VP. Torchilin VP. AAPS J. 2007 May 11;9(2):E128-47. doi: 10.1208/aapsj0902015. AAPS J. 2007. PMID: 17614355 Free PMC article. Review.

6

Cell penetrating peptides: A versatile vector for co-delivery of drug and genes in cancer.

Khan MM, Filipczak N, Torchilin VP. Khan MM, et al. J Control Release. 2021 Feb 10;330:1220-1228. doi: 10.1016/j.jconrel.2020.11.028. Epub 2020 Nov 25. J Control Release. 2021. PMID: 33248708 Review.

7

Stimuli-sensitive nanopreparations for combination cancer therapy.

Jhaveri A, Deshpande P, Torchilin V. Jhaveri A, et al. Among authors: torchilin v. J Control Release. 2014 Sep 28;190:352-70. doi: 10.1016/j.jconrel.2014.05.002. Epub 2014 May 10. J Control Release. 2014. PMID: 24818767 Review.

8

An update on dual targeting strategy for cancer treatment.

Taghipour YD, Zarebkohan A, Salehi R, Rahimi F, Torchilin VP, Hamblin MR, Seifalian A. Taghipour YD, et al. J Control Release. 2022 Sep;349:67-96. doi: 10.1016/j.jconrel.2022.06.044. Epub 2022 Jul 6. J Control Release. 2022. PMID: 35779656 Review.

9

Nanopreparations to overcome multidrug resistance in cancer.

Patel NR, Pattni BS, Abouzeid AH, Torchilin VP. Patel NR, et al. Adv Drug Deliv Rev. 2013 Nov;65(13-14):1748-62. doi: 10.1016/j.addr.2013.08.004. Epub 2013 Aug 23. Adv Drug Deliv Rev. 2013. PMID: 23973912 Free PMC article. Review.

10

Improving Peptide Applications Using Nanotechnology.

Narayanaswamy R, Wang T, Torchilin VP. Narayanaswamy R, et al. Curr Top Med Chem. 2016;16(3):253-70. doi: 10.2174/1568026615666150817100338. Curr Top Med Chem. 2016. PMID: 26279082 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters